Anaplastic Thyroid Cancer | VEOMED

Links shared publicly online about this topic.

  • 1,381
    total visits

Anaplastic Thyroid Cancer | VEOMED

veomed.com

Anaplastic Thyroid Cancer | VEOMED

View full resource at veomed.com

Tags: Cancer, Thyroid Cancer, Anaplastic Thyroid Cancer, Doctor

  • Share

Most Recently Shared on July 19, 2011 at 12:25 pm By:

VeoMed VeoMed Team

Anaplastic Thyroid Cancer. S Cunningham MD PhD F Quinn Jr MD... University of Texas Medical Branch http://ow.ly/5H1ks #thyroidcancer

2 years ago...

OXiGENE Presents Data Confirming Survival Benefit of ZYBRESTAT in Patients With Anaplastic Thyroid Cancer - MarketWatch

marketwatch.com — “OXiGENE Presents Data Confirming Survival Benefit of ZYBRESTAT in Patients With Anaplastic Thyroid Cancer - MarketWatchView full resource at marketwatch.com

  • View Related
  • Share

Most Recently Shared on September 14, 2011 at 5:34 pm By:

Endocrinology Article | Thyroid cancer

mdlinx.com — “Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 18, 2011 at 6:06 pm By:

MDLinx Sandeep Pulim MD Physician, Doctor, and Health Communicator

Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiat... http://bit.ly/dUT3t1 #endo

1 year ago...

FDA grants Exelixis XL184 orphan drug designation for treatment of medullary thyroid cancer

news-medical.net — “Exelixis, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to XL184 for treatment of follicular, medullary, and anaplastic thyroid carcinoma, and metastatic or locally advanced papillary thyroid cancer. A pivotal phase 3 trial of XL184 is ongoing in patients with medullary thyroid cancer (MTC) and the company expects to release top-line phase 3 results in the first-half of 2011 and potentially file a New Drug Application (NDA) for the coView full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 10, 2011 at 12:21 pm By:

NewsMedical News-Medical.Net Health News

FDA grants Exelixis XL184 orphan drug designation for treatment of medullary thyroid cancer: Exelixis, Inc. toda... http://bit.ly/gfelZj

1 year ago...

Endocrinology Article | Thyroid Neoplasms

mdlinx.com — “Case-Control Study of Anaplastic Thyroid Cancer: Papillary Thyroid Cancer Patients as ControlsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on December 18, 2010 at 2:22 am By:

MDLinx Sandeep Pulim MD Physician, Doctor, and Health Communicator

Case-Control Study of Anaplastic Thyroid Cancer: Papillary Thyroid Cancer Patients as Controls: The Endocr... http://bit.ly/hPJ5wB #endo

1 year ago...

NCI initiates Phase II trial with crolibulin | TradingMarkets.com

tradingmarkets.com — “TradingMarkets News for NCI initiates Phase II trial with crolibulinView full resource at tradingmarkets.com

  • View Related
  • Share

Most Recently Shared on December 17, 2010 at 8:40 pm By:

RoswellPark Roswell Park Hospital

NCI initiates Phase II trial with crolibulin in patients with Anaplastic Thyroid Cancer (ATC) http://goo.gl/vMD1t

1 year ago...

Phase 2 study of crolibulin (EPC2407) for the treatment of anaplastic thyroid cancer (ATC) - ONA

oncologynurseadvisor.com — “EpiCept announced that the National Cancer Institute (NCI) has initiated a Phase 2 trial with crolibulin (EPC2407) in combination with cisplatin for the treatment of anaplastic thyroid cancer (ATC).View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on December 15, 2010 at 7:56 pm By:

ONAcom OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education

Phase 2 study of crolibulin (EPC2407) for the treatment of anaplastic thyroid cancer (ATC) http://goo.gl/fb/Yt1QO

1 year ago...

Phase 2 study of crolibulin (EPC2407) for the treatment of anaplastic thyroid cancer (ATC) - MPR

empr.com — “EpiCept announced that the National Cancer Institute (NCI) has initiated a Phase 2 trial with crolibulin (EPC2407) in combination with cisplatin for the treatment of anaplastic thyroid cancer (ATC).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on December 15, 2010 at 7:51 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 2 study of crolibulin (EPC2407) for the treatment of anaplastic thyroid cancer (ATC): EpiCept an... http://bit.ly/h57iLL

1 year ago...

Thyroid Cancer Center: Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer

endocrineweb.com — “There are several main types of thyroid cancer: anaplastic thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, and papillary thyroid cancer. Our Thyroid Center covers each type, including diagnosis, symptoms, surgery (thyroidectomy), and other treatments (for example, radioactive iodine).View full resource at endocrineweb.com

  • View Related
  • Share

Most Recently Shared on November 6, 2010 at 3:42 pm By:

RoboticThyroidTexas Allergy & Asthma. He is among the first surgeons in North America to successfully perform robot-assisted endoscopic thyroid surgery using the daVinci Surgical System.

Dr Kuppersmith is a former President of the American Academy of Otolaryngology-Head and Neck Surgery, as well as a former President of the Texas chapter of AAO-HNS. He has received numerous awards including being selected by his peers for inclusion in the "Best Doctors in America", Texas Super Doctors as published in Texas Monthly, the “Guide to America’s Top Physicians” by the Consumers’ Research Council of America, a Distinguished Service Award and an Honor Award from the American Academy of Otolaryngology-Head and Neck Surgery.

Dr Kuppersmith has served on various Editorial Boards of prestigious otolaryngology-related publications and has authored a substantial number of scientific publications.

." /> Ronald B. Kuppersmith, MD, FACS Physician, Active Health Library, Doctor, Surgeon, and ENT Doctor

Endocrineweb Thyroid Cancer page: http://bit.ly/9YH91D

1 year ago...

Median overall survival better with combination therapy vs. chemotherapy alone for anaplastic thyroid cancer

endocrinetoday.com — “International Thyroid Congress PARIS — Patients with anaplastic thyroid cancer who received the vascular-disrupting agent fosbretabulinView full resource at endocrinetoday.com

  • View Related
  • Share

Most Recently Shared on September 15, 2010 at 6:24 am By:

EndocrineToday Endocrine Today Health News

Median overall survival better with combination therapy vs. chemotherapy alone for anaplastic #thyroid cancer http://ow.ly/2Epgk

2 years ago...

Mayo Clinic Develops Anaplastic Thyroid Cancer Cell Lines

hcplive.com — “Four new lines created from donated tumors after researchers discover they had been working with colon and melanoma cancer cells.View full resource at hcplive.com

  • View Related
  • Share

Most Recently Shared on August 25, 2010 at 8:42 pm By:

HCPLive_Endo HCPLive Endocrinology

Mayo Clinic Develops Anaplastic Thyroid Cancer Cell Lines - Previous work discovered to be on colon, melanoma cells http://hcp.lv/cmaNr7

2 years ago...

Researchers Develop New Laboratory Cell Lines To Study Treatment For Anaplastic Thyroid Cancer

medicalnewstoday.com — “To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 25, 2010 at 4:00 pm By:

mnt_endocrine MNT Endocrinology Health News

Researchers Develop New Laboratory Cell Lines To Study Treatment For Anaplastic Thyroid Cancer http://mnt.to/3HQ8 #endocrinology

2 years ago...

Researchers develop new laboratory cell lines to study treatment for ATC

physorg.com — “To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on August 25, 2010 at 11:24 am By:

FightCancer FightCancer Health News

Researchers develop new laboratory cell lines to study treatment for ATC http://bit.ly/d13HzA

2 years ago...

Researchers Develop New Laboratory Cell Lines to Study Treatment for Anaplastic Thyroid Cancer

newswise.com — “To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on August 25, 2010 at 5:18 am By:

newswise newswise Health Communicator and Health News

Researchers Develop New Laboratory Cell Lines to Study Treatment for Anaplastic Thyroid Cancer: To their deep dism... http://bit.ly/dnJ6RK

2 years ago...

New treatment approach to rare cancer results in prolonged survival - News

virtualmedicalcentre.com — “Aggressive treatment of anaplastic thyroid carcinoma has dramatically increased survival in the small group of patients who chose to undergo it.View full resource at virtualmedicalcentre.com

  • View Related
  • Share

Most Recently Shared on June 23, 2010 at 2:15 pm By:

VirtualMedical VirtualMedicalCentre Health Site

New treatment approach to rare cancer results in prolonged survival http://dlvr.it/1yjGS

2 years ago...

New Treatment Approach To Rare Cancer Results In Prolonged Survival

medicalnewstoday.com — “Aggressive treatment of anaplastic thyroid carcinoma has dramatically increased survival in the small group of patients who chose to undergo it, say physicians at Mayo Clinic. Their findings willView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 27, 2010 at 3:13 pm By:

mnt_cancer MNT Cancer News Health News

New Treatment Approach To Rare Cancer Results In Prolonged Survival http://mnt.to/3D8T #cancer

2 years ago...

Advertisement